Clinical trial
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer
NCT03345420
Study timeline
Study start (actual)2017-12-12Date precision: day
Registry last updated2025-12-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Ductal Breast Carcinoma In Situunresolved
Invasive Breast Carcinomaunresolved
Stage 0 Breast Cancerunresolved
Stage I Breast Cancerunresolved
Stage IA Breast Cancerunresolved
Stage IB Breast Cancerunresolved
Stage II Breast Cancerunresolved
Stage IIA Breast Cancerunresolved
Stage IIB Breast Cancerunresolved
Interventions
Hypofractionated Radiation TherapyRADIATION
Sponsors & collaborators
University of Utahlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03345420 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.